- Our Doctors
- Dr Rebecca Shakir
Dr Rebecca Shakir
MBBS, BSc (Hons), DPhil, MRCP, FRCR Consultant Clinical Oncologist
Languages spoken
English
Expert in
Head & Neck cancer, Skin cancer
Overview
Centre
Dr Rebecca Shakir is a Consultant Clinical Oncologist based at the Churchill Hospital in Oxford, and a post-doctoral academic visitor at Oxford Population Health. She focuses on the treatment of skin cancers, including melanoma and non-melanoma skin cancer, using advanced radiotherapy techniques such as electron and photon therapy, alongside systemic treatments. She also specialises in supporting patients experiencing long-term or late effects following cancer treatment.
Alongside her clinical practice, Dr Shakir is actively involved in research and education, with academic interests in clinical trials, innovations in radiotherapy delivery and medical teaching.
Dr Shakir graduated from Imperial College School of Medicine in 2009. She went on to complete her specialist training in clinical oncology, gaining Fellowship of the Royal College of Radiologists in 2018. She subsequently finished her doctoral studies at the University of Oxford in 2022. This research focussed on the balance of benefits and risks associated with radiotherapy after chemotherapy for lymphoma, supported by a National Institute for Health and Care Research (NIHR) Doctoral Research Fellowship.
Following completion of her academic training, she was appointed as a Consultant Clinical Oncologist in 2023. In addition to treating patients, she contributes to the development of specialist services for individuals living with the long-term consequences of cancer treatment, including involvement in a Macmillan-funded adult radiotherapy late-effects service in Oxford. She also supports the established late-effects service for paediatric and young adult patients.
Dr Shakir is also committed to education and training. She is the Sherrington Lecturer at Magdalen College, Oxford, and is a member of the Specialty Training Board at the Royal College of Radiologists.
Expertise and interests
- Electron radiotherapy for treatment of non-melanoma skin cancer
- Photon radiotherapy for treatment of melanoma and non-melanoma skin cancer
- Systemic therapy for non-melanoma skin cancer
- Technical radiotherapy techniques
- Medical education
- Clinical trials
Professional memberships
- Fellow of the Royal College of Radiologists
- Member of the Royal College of Physicians
- Member of the British Association of Head & Neck Oncologists
- Member of the European Society for Radiotherapy and Oncology
Awards
- NIHR Doctoral Fellowship (2020)
- Outstanding performance in Master of Science in Oncology, Institute of Cancer Research (2020)
Publications and Affiliations
1.1. Green H, Rieu R, Slevin F, Ashmore L, Bulbeck H, Gkogkou P, Ingram S, Kelly C, Probst H, Shakir R, Underwood T, Wolfarth J, Merchant MJ, Burnet NG; CTRad Working Group 4. Best Practice for Patient-centred Radiotherapy in Clinicial Trials and Beyond – A National Multidisciplinary Consensus. Clinical Oncology 2024 December; 17 (39); doi.org/10.1016/j.clon.2024.103732
2. Jones DA, Spencer K, Ramroth J, Probert J, Roope LSJ, Shakir R, Broggio J, Burroughs F, Collins GP, Clarke PM, Wolstenholme JL, Cutter DJ. Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England. British Journal of Haematology 2024 November; 27; doi.org/10.1111/bjh.19907
3. Baxter MA, Denholm M, Kingdon SJ, Kathirgamakarthigeyan S, Parikh S, Shakir R, Johnson R, Martin H, Walton M, Yao W, Swan A, Samuelson C, Ren X, Cooper A, Gray HL, Clifton S, Ball J, Gullick G, Anderson M, Dodd L, Hayhurst H, Salama M, Shotton R, Britton F, Christodoulou T, Abdul-Hamid A, Eichholz A, Evans RM, Wallroth P, Gibson F, Poole K, Rowe M, Harris J; National Oncology Trainees Collaborative for Heathcare Research (NOTCH). CAnceR IN PreGnancy (CARING) – a retrospective study of cancer diagnosed during pregnancy in the United Kingdom.
4. Ramroth J, Shakir R, Darby SC, Cutter DJ, Kuan V. Cardiovascular disease incidence rates: a study using routinely collected health data. Cardiooncology 2023 November; 9 (1): 41; doi.org/10.1186/s40959-023-00189-8
5. Guerts Y*, Shakir R*, Ntentas G, Roberti S, Aznar M, John K, Ramroth J, Krol A, Roesink J, van der Maazen R, Zijlstra J, Darby S, Aleman B, van Leeuwen F, Cutter D, Schaapveld M. Association of radiation and procarbazine dose with colorectal cancer among survivors of Hodgkin lymphoma. JAMA Oncology 2023 February; 9 (4): 481-489; doi.org/10.1001/jamaoncol.2022.7153